Biomarin Pharmaceuticals (BMRN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2000 | 12-1999 | 12-1998 | |
| Sales | 9,714 | 5,300 | 1,190 |
| Cost of Goods | N/A | N/A | 100 |
| Gross Profit | 9,714 | 5,300 | 1,080 |
| Operating Expenses | 45,389 | 31,098 | 14,130 |
| Operating Income | -35,675 | -25,798 | -12,940 |
| Interest Expense | 7 | 732 | 0 |
| Other Income | 67 | 159 | 630 |
| Pre-tax Income | -35,615 | -26,371 | -12,310 |
| Net Income Continuous | -35,615 | -26,371 | -12,314 |
| Net Income Discontinuous | -1,749 | -1,701 | 0 |
| Net Income | $-37,364 | $-28,072 | $-12,310 |
| EPS Basic Total Ops | -1.04 | -0.94 | -0.55 |
| EPS Basic Continuous Ops | -0.99 | -0.88 | -0.55 |
| EPS Basic Discontinuous Ops | -0.05 | -0.06 | N/A |
| EPS Diluted Total Ops | -1.04 | -0.94 | -0.55 |
| EPS Diluted Continuous Ops | -0.99 | -0.88 | -0.55 |
| EPS Diluted Discontinuous Ops | -0.05 | -0.06 | N/A |
| EBITDA(a) | $-29,942 | $-20,383 | $-12,180 |